Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
glaxosmithkline
6
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
abbvie
amgen
fda
biogen
bristol-myers squibb
cancer
duchenne muscular dystrophy
eli lilly
europe blog main
europe top stories
gene therapy
What
bio
6
×
roundup
6
×
days
abbvie’s
cancer
day
labor
opioid
advanced
ahead
alliance
arrival
august
award
barbecuing
biofourmis
biotech
black
bristol
bucks
busy
buy
calls
camping
cardiologist
celebrate
center
chance
changing
check
cholesterol
color
companies
conference
continue
corner
crispr
data
death
debut
Language
unset
6
×
Current search:
glaxosmithkline
×
bio
×
roundup
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More